TNS4 and colorectal carcinoma: It has been argued that TNS4 plays a pivotal role in CRC tumorigenesis, suggesting that TNS4 suppression could represent a promising therapeutic approach [39] and its knockdown improves sensitivity to Gefitinib [40].